Primary pulmonary hypertension, Castleman's disease and human herpesvirus‐8
暂无分享,去创建一个
D. Badesch | N. Voelkel | M. Geraci | J. Parr | T. Campbell | T. Bull | C. Cool | A. Serls | J. Parr | D. Badesch | P. P. Rai | M. Geraci | J. Neid | P. Rai | C. Cool | T.B. Campbell | Pradeep R. Rai | N. F. Voelkel | Todd Bull | James M. Neid | Thomas B. Campbell
[1] N. Voelkel,et al. The pathobiology of pulmonary hypertension. Endothelium. , 2001, Clinics in chest medicine.
[2] D. Resnick,et al. Plasma Cell Dyscrasia with Polyneuropathy, Organomegaly, Endocrinopathy, M Protein, and Skin Changes: The POEMS Syndrome REPORT ON TWO CASES AND A REVIEW OF THE LITERATURE , 1980, Medicine.
[3] P. Simmonds,et al. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen , 1996, The Lancet.
[4] E. Cesarman,et al. Polymerase chain reaction detection of Kaposi's sarcoma-associated herpesvirus-optimized protocols and their application to myeloma. , 2001, The Journal of molecular diagnostics : JMD.
[5] J. Herrada,et al. The Clinical Behavior of Localized and Multicentric Castleman Disease , 1998, Annals of Internal Medicine.
[6] J. Shellito,et al. Pulmonary Hypertension Associated With HIV Infection , 2001, Southern medical journal.
[7] K. Kaibuchi,et al. Elongation Factor-1α Is a Novel Substrate of Rho-Associated Kinase , 2000 .
[8] N. Voelkel,et al. Vascular Endothelial Growth Factor in Pulmonary Hypertension , 1996, Annals of the New York Academy of Sciences.
[9] K. Kaibuchi,et al. Elongation factor-1 alpha is a novel substrate of rho-associated kinase. , 2000, Biochemical and biophysical research communications.
[10] S. Rich,et al. Primary pulmonary hypertension: a vascular biology and translational research "Work in progress". , 2000, Circulation.
[11] N. Voelkel,et al. Primary pulmonary hypertension between inflammation and cancer. , 1998, Chest.
[12] N. Voelkel,et al. Microsatellite Instability of Endothelial Cell Growth and Apoptosis Genes Within Plexiform Lesions in Primary Pulmonary Hypertension , 2001, Circulation research.
[13] Irene E. White,et al. Quantitation of Cell-Free and Cell-Associated Kaposi's Sarcoma-Associated Herpesvirus DNA by Real-Time PCR , 2000, Journal of Clinical Microbiology.
[14] P. Monini,et al. Biology of Kaposi's sarcoma. , 2001, European journal of cancer.
[15] G. Barbarini,et al. Primary Pulmonary Hypertension in HIV Patients: A Systematic Review , 2001, Angiology.
[16] A. Wald,et al. Assessment of a Combined Testing Strategy for Detection of Antibodies to Human Herpesvirus 8 (HHV-8) in Persons with Kaposi's Sarcoma, Persons with Asymptomatic HHV-8 Infection, and Persons at Low Risk for HHV-8 Infection , 2002, Journal of Clinical Microbiology.
[17] I. Maruyama,et al. Increased Expression of Vascular Endothelial Growth Factor (VEGF) in Castleman's Disease: Proposed Pathomechanism of Vascular Proliferation in the Affected Lymph Node , 2000, Leukemia & lymphoma.
[18] J. Dillner,et al. Laboratory Diagnosis of Human Herpesvirus 8 Infection in Humans , 2002, European Journal of Clinical Microbiology and Infectious Diseases.
[19] K. Shroyer,et al. Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension. , 1998, The Journal of clinical investigation.
[20] F. Authier,et al. Pulmonary hypertension in POEMS syndrome: a new feature mediated by cytokines. , 1998, American journal of respiratory and critical care medicine.
[21] M. Humbert,et al. Imbalance between platelet vascular endothelial growth factor and platelet-derived growth factor in pulmonary hypertension. Effect of prostacyclin therapy. , 2000, American journal of respiratory and critical care medicine.
[22] P. Gaulard,et al. Human herpesvirus 8 infection in patients with POEMS syndrome-associated multicentric Castleman's disease. , 1999, Blood.
[23] S. Winter,et al. Elevated levels of tumor necrosis factor-beta, gamma-interferon, and IL-6 mRNA in Castleman's disease. , 1996, Medical and pediatric oncology.